The following market research report is for the ever-changing, ever-evolving Breast Cancer Screening market in United States. The current report is the most updated report you will find on the United States Breast Cancer Screening market. Using 2020 and preceding years as the base, the report carries accurate data on the forecasts from the year 2020 to 2025. From current statistics, facts and figures of the industry to the future prospects, business strategies and revenue of the biggest operators in the industry, you will find all the data that’s been thoroughly cross-checked and verified by the finest authors and researchers. Keyplayers and more - all the biggest companies operating in the United States Breast Cancer Screening market have been profiled and analyzed in the report as well.
United States Breast Cancer Screening Market is expected to reach more than US$ 5.8 Billion by 2022.
Long–term Growth Projection:
• Mammography grasp the dominant share in the United States Breast Cancer Screening Market
• Breast MRI Screening market is likely to reach more than US$ 350 Million by 2022
• Number of mammograpy screening population in United States will increase to more than 50 Million by 2022
Market growth can be attributed to factors such as increasing incidence of breast cancer, increasing awareness related to early breast cancer detection, growing government investments and funding for breast cancer screening, technological advancement in breast imaging technologies and implementation of several initiatives to create awareness about the early detection of breast cancer.
“United States Breast Cancer Screening Market Analysis: By Type, Share, Cases, Clinical Trials Insight, Reimbursement, Competitive Strategies and Forecast, 2017 - 2022” provides a deep and thorough evaluation of the United States Breast Cancer Screening Market. The report provides an in–depth analysis of the breast cancer invasive, in situ and men cases and added breast cancer death figures of both men and women in United States. Furthermore, the report also covered mammography screening population from 2010 to 2022.
Market outlook in value terms has been analyzed based on historical, current and potential trends and the market is projected from 2017 to 2022. The breast cancer screening market is segmented based on its product types: Mammography, Breast MRI and Breast Ultrasound. Additionally, the report includes assessment of clinical trials and reimbursement pattern. The report also explores detailed description of growth drivers and inhibitors of the United States Breast Cancer Screening Market.
The report concludes with the profiles of major manufacturers of Mammography, MRI and Ultrasound such as Hologic, Hitachi Medical Corporation, Siemen Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation and GE Healthcare. The major manufacturers are evaluated on various parameters such as business overview, marketed products and latest development and trends
Key Topics
Covered in the Report
• United States Breast Cancer Cases (2010 - 2022)
• United States Breast Cancer Mammography Screening Population (2010 – 2022)
• United States Breast Cancer Death (2010 – 2017)
• Market Overview: United States Breast Cancer Screening (2010 – 2022)
• Market Share: United States Breast Cancer Screening (2010 – 2022)
• By Types (Mammography, Breast MRI & Breast Ultrasound): Market Size & Analysis (2010 – 2022)
• Reimbursement Policies of the United States Breast Cancer Screening
• Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
• Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
• Key Manufacturers Analysis
Major Breast Cancer Screening Analyzed Under This Report Are:
• Mammography
• Breast Magnetic Resonance Imaging(MRI)
• Breast Ultrasound
Major Companies Covered in This Report:
• Hitachi Medical Corporation
• Siemen Healthineers
• Philips Healthcare
• Toshiba Medical Systems Corporation
• GE Healthcare
• Hologic
The report contains qualitative analysis, quantitative analysis and even regional analysis of major markets to cover all aspects of the United States Breast Cancer Screening market. You can use this report for investments or business strategies. Get in touch with Market Research Port today for the best price on the United States Breast Cancer Screening market research report.
Table of Contents
1. Executive Summary
2. Breast Cancer Facts
3. United States Breast Cancer Cases & Population (2010 – 2022)
3.1 Breast Cancer Mammography Screening Population (2010 – 2022)
3.2 Breast Cancer Occurrence (2010–2022)
3.2.1 Total Breast Cancer Cases
3.2.1.1 Breast Cancer Invasive Cases
3.2.1.2 Breast Cancer In Situ Cases
3.2.1.3 Breast Cancer Men Cases
3.3 Breast Cancer Death (2010 – 2017)
3.3.1 Total Breast Cancer Death
3.3.1.1 Women Breast Cancer Death
3.3.1.2 Men Breast Cancer Death
4. Market Overview: United States Breast Cancer Screening (2010 – 2022)
5. Market Share: United States Breast Cancer Screening (2010 – 2022)
6. By Types: Market Size & Analysis (2010 – 2022)
6.1 Mammography Screening Market
6.2 Breast Magnetic Resonance Imaging (MRI) Screening Market
6.3 Breast Ultrasound Screening Market
7. Key Drivers and Inhibitors of the United States Breast Cancer Screening Market
7.1 Market Drivers
7.2 Market Inhibitors
8. Reimbursement Policies of the United States Breast Cancer Screening
8.1 Mammography
8.2 Breast Magnetic Resonance Imaging(MRI)
8.3 Breast Ultrasound
9. Breast Cancer Screening Market Clinical Trail Insight by Phase, Company & Country
9.1 Year 2017
9.2 Year 2016
9.3 Year 2015
10. Key Manufacturers Analysis
10.1 Hologic
10.1.1 Business Overview
10.1.2 Breast Cancer Screening – Marketed Products
10.1.2.1 Mammography
10.1.2.2 Magnetic Resonance Imaging(MRI)
10.1.3 Breast Cancer Screening – Latest Development & Trends
10.2 Hitachi Medical Corporation
10.2.1 Business Overview
10.2.2 Breast Cancer Screening – Marketed Products
10.2.2.1 Magnetic Resonance Imaging(MRI)
10.2.2.2 Ultrasound
10.2.3 Breast Cancer Screening – Latest Development & Trends
10.3 Siemens Healthineers
10.3.1 Business Overview
10.3.2 Breast Cancer Screening – Marketed Products
10.3.2.1 Mammography
10.3.2.2 Magnetic Resonance Imaging (MRI)
10.3.3 Breast Cancer Screening – Latest Development & Trends
10.4 Philips Healthcare
10.4.1 Business Overview
10.4.2 Breast Cancer Screening – Marketed Products
10.4.2.1 Mammography
10.4.2.2 Magnetic Resonance Imaging (MRI)
10.4.2.3 Ultrasound
10.4.3 Breast Cancer Screening – Latest Development & Trends
10.5 Toshiba Medical Systems Corporation
10.5.1 Business Overview
10.5.2 Breast Cancer Screening – Marketed Products
10.5.2.1 Mammography
10.5.2.2 Magnetic Resonance Imaging (MRI)
10.5.2.3 Ultrasound
10.5.3 Breast Cancer Screening – Latest Development & Trends
10.6 GE Healthcare
10.6.1 Business Overview
10.6.2 Breast Cancer Screening – Marketed Products
10.6.2.1 Mammography
10.6.2.2 Magnetic Resonance Imaging (MRI)
10.6.2.3 Ultrasound
10.6.3 Breast Cancer Screening – Latest Development & Trends